These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2090343)

  • 1. [Disposition of [3H]flobufen and its active metabolite in rats].
    Lapka R; Brejcha A; Smolík S; Franc Z
    Cesk Farm; 1990 Dec; 39(10):443-7. PubMed ID: 2090343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of flobufen and its main active metabolite in the rat.
    Lapka R; Smolík S; Rejholec V
    Drug Metab Dispos; 1990; 18(6):1060-4. PubMed ID: 1981513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective pharmacokinetics and metabolism of flobufen in guinea pigs.
    Trejtnar F; Král R; Pávek P; Wsól V
    Chirality; 2003 Oct; 15(8):724-9. PubMed ID: 12923810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic pathways of flobufen-a new antirheumatic and antiarthritic drug. Interspecies comparison.
    Kvasnicková E; Szotáková B; Wsól V; Trejtnar F; Skálová L; Hais IM; Kuchar M; Poppová M
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):352-6. PubMed ID: 10445396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective pharmacokinetics of flobufen in rats.
    Trejtnar F; Wsol V; Szotakova B; Skalova L; Pavek P; Kuchar M
    Chirality; 1999; 11(10):781-6. PubMed ID: 10561708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
    Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
    Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of aromatic amino acid decarboxylases by the anti-inflammatory agent flobufen and 2',4'-difluorbiphenyl-4-acetic acid].
    Drsata J; Pribová M; Hais IM
    Cesk Farm; 1989 Nov; 38(9):407-10. PubMed ID: 2635645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disposition of the potential antidepressive agent (3H) VUFB 15468 in mice and rats].
    Lapka R; Brejcha A; Smolík S
    Cesk Farm; 1990 Jul; 39(6):258-60. PubMed ID: 2078864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
    Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
    Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecificity and stereoselectivity of flobufen metabolic profile in male rats in vitro and in vivo: phase I of biotransformation.
    Wsól V; Král R; Skálová L; Szotáková B; Trejtnar F; Flieger M
    Chirality; 2001; 13(10):754-9. PubMed ID: 11746815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecificity of flobufen metabolism in guinea pigs in vitro and in vivo: phase I of biotransformation.
    Kral R; Skalova L; Szotakova B; Babu YN; Wsol V
    Chirality; 2004 Jan; 16(1):1-9. PubMed ID: 14628293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 4-acetylaminophenylacetic acid. 2nd communication: tissue accumulation and enzyme induction in rats after repeated administration, and placental and milk transfer after single dosing.
    Sugihara K; Morino A; Sugiyama M; Iida S; Nomura A
    Arzneimittelforschung; 1990 Jul; 40(7):806-10. PubMed ID: 2222557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of flobufen in pig hepatocytes: effect of pig breed (domestic, wild) and castration.
    Skálová L; Wsól V; Baliharová V; Král R; Szotáková B; Velík J; Lamka J
    Chirality; 2003 Mar; 15(3):213-9. PubMed ID: 12582986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat].
    Kopitar Z; Zimmer A
    Arzneimittelforschung; 1976; 26(7a):1435-41. PubMed ID: 1036935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of naproxen.
    Davies NM; Anderson KE
    Clin Pharmacokinet; 1997 Apr; 32(4):268-93. PubMed ID: 9113437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral aspects of metabolism of antiinflammatory drug flobufen in human hepatocytes.
    Skálová L; Král R; Szotáková B; Babú YN; Pichard-Garcia L; Wsól V
    Chirality; 2003 May; 15(5):433-40. PubMed ID: 12692889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.